[Effects of catecholamines on the neuromuscular blocking action of a non-depolarizing muscle relaxant--Part II. Experimental studies on the anti-neuromuscular blocking actions of catecholamines and the mechanisms of these actions in the dog].
Omote
T
T
Namiki
A
A
Iwasaki
H
H
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D004285:Dogs; D009466:Neuromuscular Blocking Agents / Q000037:antagonists & inhibitors*; D010197:Pancuronium / Q000037:antagonists & inhibitors*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D009466:Neuromuscular Blocking Agents; D010197:Pancuronium